EMEA: Concept paper on the need for revision of the CHMP note for guidance on the clinical development of medicinal products in the treatment of asthma

The CHMP note for guidance on the clinical investigation of medicinal products in the treatment of asthma came into operation in May 2003. Since then, it has been proven to be useful for both industry and regulators in the development and assessment of products aimed to treating asthma.